SiRNA knock-down of rank signaling to control osteoclast-mediated bone resorption

Pharmaceutical Research

Volumn 27, Issue 7, 2010, Pages 1273-1284

  Wang, Yuwei ^a   Grainger, David W ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b Department of Electrical and Computer Engineering   (United States)

Author keywords

Bone resorption; Macrophage; Osteoclasts; RANK; Small interfering RNA

Indexed keywords

MESSENGER RNA; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SMALL INTERFERING RNA; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; BONE MARROW CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; GENE REPRESSION; GENE TARGETING; GENETIC TRANSFECTION; GROWTH INHIBITION; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; STEM CELL; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; WESTERN BLOTTING; ANIMAL; BOVINAE; CELL DIFFERENTIATION; CELL LINE; GENE SILENCING; GENETICS; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BLOTTING, WESTERN; BONE RESORPTION; CATTLE; CELL DIFFERENTIATION; CELL LINE; GENE KNOCKDOWN TECHNIQUES; MICE; OSTEOCLASTS; RANK LIGAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 77953621091     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0099-5     Document Type: Article

References (57)

1. J LaFleur C McAdam-Marx C Kirkness DI Brixner 2008 Clinical risk factors for fracture in postmenopausal osteoporotic women: a review of the recent literature Ann Pharmacother 42 375 86 10.1345/aph.1K203 18230704 (Pubitemid 351429603)
2. EM Lewiecki 2009 Managing osteoporosis: challenges and strategies Cleve Clin J Med 76 457 66 10.3949/ccjm.76a.09019 19652039
3. NB Watts 2010 Bone: bone density screening leads to reduced fracture risk Nat Rev Endocrinol 6 17 8 10.1038/nrendo.2009.246 20010967
4. P Ducy T Schinke G Karsenty 2000 The osteoblast: a sophisticated fibroblast under central surveillance Science 289 1501 4 10.1126/science.289. 5484.1501 1:CAS:528:DC%2BD3cXmt1KgsLg%3D 10968779
5. AL Langston SH Ralston 2004 Management of Paget's disease of bone Rheumatology (Oxford) 43 955 9 10.1093/rheumatology/keh243 1:CAS:528: DC%2BD2cXlsl2rs70%3D (Pubitemid 39144439)
6. NIH Consensus Development Panel on Osteoporosis Prevention, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785-95.
7. JR Berenson 2002 Treatment of hypercalcemia of malignancy with bisphosphonates Semin Oncol 29 12 8 10.1053/sonc.2002.37417 1:CAS:528: DC%2BD3sXhslOnsrs%3D 12584690
8. RE Coleman 2004 Bisphosphonates: clinical experience Oncologist 9 Suppl 4 14 27 10.1634/theoncologist.9-90004-14 1:CAS:528:DC%2BD2cXpslGhtbs%3D 15459426 (Pubitemid 39363165)
9. LG Raisz 1999 Physiology and pathophysiology of bone remodeling Clin Chem 45 1353 8 1:CAS:528:DyaK1MXltFGnurc%3D 10430818
10. DA Corral M Amling M Priemel E Loyer S Fuchs P Ducy, et al. 1998 Dissociation between bone resorption and bone formation in osteopenic transgenic mice Proc Natl Acad Sci USA 95 13835 40 10.1073/pnas.95.23.13835 1:CAS:528:DyaK1cXnsVGmtLs%3D 9811887 (Pubitemid 28523059)
11. WC Dougall M Glaccum K Charrier K Rohrbach K Brasel T De Smedt, et al. 1999 RANK is essential for osteoclast and lymph node development Genes Dev 13 2412 24 10.1101/gad.13.18.2412 1:CAS:528:DyaK1MXmsVCgtr4%3D 10500098 (Pubitemid 29453612)
12. J Li I Sarosi XQ Yan S Morony C Capparelli HL Tan, et al. 2000 RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism Proc Natl Acad Sci USA 97 1566 71 10.1073/pnas.97.4.1566 1:CAS:528:DC%2BD3cXhsFCrsL4%3D 10677500 (Pubitemid 30118482)
13. DL Lacey HL Tan J Lu S Kaufman G Van W Qiu, et al. 2000 Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo Am J Pathol 157 435 48 1:CAS:528:DC%2BD3cXlvFyqsro%3D 10934148
14. W Jochum JP David C Elliott A Wutz H Plenk Jr K Matsuo, et al. 2000 Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1 Nat Med 6 980 4 10.1038/79676 1:CAS:528: DC%2BD3cXms12lt7s%3D 10973316
15. YY Kong H Yoshida I Sarosi HL Tan E Timms C Capparelli, et al. 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis Nature 397 315 23 10.1038/16852 1:CAS:528:DyaK1MXhtVOqs7w%3D 9950424 (Pubitemid 29061638)
16. MA Lomaga WC Yeh I Sarosi GS Duncan C Furlonger A Ho, et al. 1999 TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling Genes Dev 13 1015 24 10.1101/gad.13.8.1015 1:CAS:528: DyaK1MXivFGkurY%3D 10215628
17. WS Simonet DL Lacey CR Dunstan M Kelley MS Chang R Luthy, et al. 1997 Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 309 19 10.1016/S0092-8674(00)80209-3 1:CAS:528: DyaK2sXislCgtLc%3D 9108485
18. T Akatsu T Murakami M Nishikawa K Ono N Shinomiya E Tsuda, et al. 1998 Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast Biochem Biophys Res Commun 250 229 34 10.1006/bbrc.1998.9294 1:CAS:528:DyaK1cXmt1ygs7Y%3D 9753612 (Pubitemid 28463860)
19. JG Emery P McDonnell MB Burke KC Deen S Lyn C Silverman, et al. 1998 Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL J Biol Chem 273 14363 7 10.1074/jbc.273.23.14363 1:CAS:528:DyaK1cXjs1Oru70%3D 9603945 (Pubitemid 28319153)
20. A Fire S Xu MK Montgomery SA Kostas SE Driver CC Mello 1998 Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 391 806 11 10.1038/35888 1:CAS:528:DyaK1cXhtlCju74%3D 9486653 (Pubitemid 28099681)
21. L Aagaard JJ Rossi 2007 RNAi therapeutics: principles, prospects and challenges Adv Drug Deliv Rev 59 75 86 10.1016/j.addr.2007.03.005 1:CAS:528:DC%2BD2sXlvVOhtLw%3D 17449137 (Pubitemid 46770900)
22. KA Woodrow Y Cu CJ Booth JK Saucier-Sawyer MJ Wood WM Saltzman 2009 Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA Nat Mater 8 526 33 10.1038/nmat2444 1:CAS:528:DC%2BD1MXmtFems7Y%3D 19404239
23. JC Reichert S Saifzadeh ME Wullschleger DR Epari MA Schutz GN Duda, et al. 2009 The challenge of establishing preclinical models for segmental bone defect research Biomaterials 30 2149 63 10.1016/j.biomaterials.2008.12.050 1:CAS:528:DC%2BD1MXisVCmur8%3D 19211141
24. M Takanashi K Oikawa K Sudo M Tanaka K Fujita A Ishikawa, et al. 2009 Therapeutic silencing of an endogenous gene by siRNA cream in an arthritis model mouse Gene Ther 16 982 9 10.1038/gt.2009.66 1:CAS:528:DC%2BD1MXmsVOqs7o%3D 19474812
25. D Massaro GD Massaro LB Clerch 2004 Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in mice Am J Physiol Lung Cell Mol Physiol 287 L1066 70 10.1152/ajplung.00067.2004 1:CAS:528: DC%2BD2cXhtVaqsLjP 15234906 (Pubitemid 39391038)
26. DR Thakker F Natt D Husken R Maier M Muller H van der Putten, et al. 2004 Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference Proc Natl Acad Sci USA 101 17270 5 10.1073/pnas.0406214101 1:CAS:528:DC%2BD2cXhtFansr7J 15569935 (Pubitemid 39627809)
27. LM Chamberlain ML Godek M Gonzalez-Juarrero DW Grainger 2009 Phenotypic non-equivalence of murine (monocyte-) macrophage cells in biomaterial and inflammatory models J Biomed Mater Res A 88 858 71 18357567
28. M Takami N Kim J Rho Y Choi 2002 Stimulation by toll-like receptors inhibits osteoclast differentiation J Immunol 169 1516 23 1:CAS:528: DC%2BD38XlslWht7c%3D 12133979
29. Y Wang D Lebowitz C Sun H Thang MD Grynpas M Glogauer 2008 Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis J Bone Miner Res 23 260 70 10.1359/jbmr.071013 1:CAS:528:DC%2BD1cXhvVOhtro%3D 17922611 (Pubitemid 351160040)
30. I Lambrinoudaki G Christodoulakos D Botsis 2006 Bisphosphonates Ann NY Acad Sci 1092 397 402 10.1196/annals.1365.036 1:CAS:528:DC%2BD2sXjtlajt70%3D 17308164 (Pubitemid 47092356)
31. KD Hausler NJ Horwood Y Chuman JL Fisher J Ellis TJ Martin, et al. 2004 Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation J Bone Miner Res 19 187381 10.1359/JBMR.040807 (Pubitemid 41103439)
32. DP Trebec D Chandra A Gramoun K Li JN Heersche MF Manolson 2007 Increased expression of activating factors in large osteoclasts could explain their excessive activity in osteolytic diseases J Cell Biochem 101 205 20 10.1002/jcb.21171 1:CAS:528:DC%2BD2sXkvFeku7k%3D 17216600 (Pubitemid 46652585)
33. N Nakagawa M Kinosaki K Yamaguchi N Shima H Yasuda K Yano, et al. 1998 RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis Biochem Biophys Res Commun 253 395 400 10.1006/bbrc.1998.9788 1:CAS:528:DyaK1MXhs12ntw%3D%3D 9878548 (Pubitemid 29026714)
34. WJ Boyle WS Simonet DL Lacey 2003 Osteoclast differentiation and activation Nature 423 337 42 10.1038/nature01658 1:CAS:528:DC%2BD3sXjs1ynu7g%3D 12748652 (Pubitemid 40852708)
35. T Suda N Takahashi N Udagawa E Jimi MT Gillespie TJ Martin 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families Endocr Rev 20 345 57 10.1210/er.20.3.345 1:CAS:528:DyaK1MXktVaqtLg%3D 10368775
36. PJ Kostenuik C Capparelli S Morony S Adamu G Shimamoto V Shen, et al. 2001 OPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats Endocrinology 142 4295 304 10.1210/en.142.10.4295 1:CAS:528:DC%2BD3MXnt1ert70%3D 11564687 (Pubitemid 32907057)
37. PJ Bekker D Holloway A Nakanishi M Arrighi PT Leese CR Dunstan 2001 The effect of a single dose of osteoprotegerin in postmenopausal women J Bone Miner Res 16 348 60 10.1359/jbmr.2001.16.2.348 1:CAS:528:DC%2BD3MXptlOquw%3D%3D 11204435
38. DD Breimer 1999 Future challenges for drug delivery J Control Release 62 3 6 10.1016/S0168-3659(99)00060-7 1:CAS:528:DyaK1MXmsV2rurg%3D 10518628 (Pubitemid 29486475)
39. MR DeFelippis RE Chance BH Frank 2001 Insulin self-association and the relationship to pharmacokinetics and pharmacodynamics Crit Rev Ther Drug Carrier Syst 18 201 64 1:CAS:528:DC%2BD3MXjs1ehs7w%3D 11325032
40. Akers MJ, DeFelippis MR. Peptides and proteins as parenteral solutions. In: Frokjaer S, Hovgaard L, editors. Pharmaceutical formulation development of peptides and proteins. London: Taylor & Francis. 2000; p. 145-77.
41. PD Miller 2009 Denosumab: anti-RANKL antibody Curr Osteoporos Rep 7 18 22 10.1007/s11914-009-0004-5 19239825
42. EM Lewiecki 2009 Is denosumab better than alendronate in the treatment of osteoporosis? Nat Clin Pract Rheumatol 5 72 3 10.1038/ncprheum0981 1:CAS:528:DC%2BD1MXht1ansb4%3D 19092832
43. Gerstenfeld LC, Sacks DJ, Pelis M, Mason ZD, Graves DT, Barrero M, Ominsky MS, Kostenuik PJ, Morgan EF, Einhorn TA. Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing. J Bone Miner Res. 2009; 24:196-208.
44. R Almeida RC Allshire 2005 RNA silencing and genome regulation Trends Cell Biol 15 251 8 10.1016/j.tcb.2005.03.006 1:CAS:528:DC%2BD2MXjslKhsb4%3D 15866029 (Pubitemid 40603894)
45. JW Myers JT Jones T Meyer JE Ferrell Jr 2003 Recombinant dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing Nat Biotechnol 21 324 8 10.1038/nbt792 1:CAS:528:DC%2BD3sXhsFajs7g%3D 12592410 (Pubitemid 36314820)
46. LD Kumar AR Clarke 2007 Gene manipulation through the use of small interfering RNA (siRNA): from in vitro to in vivo applications Adv Drug Deliv Rev 59 87 100 10.1016/j.addr.2007.03.009 1:CAS:528:DC%2BD2sXlvVOhtL0%3D 17434644 (Pubitemid 46770901)
47. SS Bajammal M Zlowodzki A Lelwica P Tornetta 3rd TA Einhorn R Buckley, et al. 2008 The use of calcium phosphate bone cement in fracture treatment. A meta-analysis of randomized trials J Bone Jt Surg Am 90 1186 96 10.2106/JBJS.G.00241 (Pubitemid 351778124)
48. An YH. Internal fixation in osteoporotic bone. New York: Thieme Medical Publishers. 2002.
49. Hughes P, Marshall D, Reid Y, Parkes H, Gelber C. The costs of using unauthenticated, over-passaged cell lines: how much more data do we need? Biotechniques 2007;43, 575, 577-8, 581-2 passim.
50. ML Godek JA Sampson NL Duchsherer Q McElwee DW Grainger 2006 Rho GTPase protein expression and activation in murine monocytes/macrophages is not modulated by model biomaterial surfaces in serum-containing in vitro cultures J Biomater Sci Polym Ed 17 1141 58 10.1163/156856206778530731 1:CAS:528: DC%2BD28Xht1yksrbJ 17235380 (Pubitemid 44593440)
51. DW Bartlett ME Davis 2006 Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging Nucleic Acids Res 34 322 33 10.1093/nar/gkj439 1:CAS:528:DC%2BD28Xmsl2lug%3D%3D 16410612 (Pubitemid 43160055)
52. XH Liu A Kirschenbaum S Yao AC Levine 2006 Interactive effect of interleukin-6 and prostaglandin E2 on osteoclastogenesis via the OPG/RANKL/RANK system Ann NY Acad Sci 1068 225 33 10.1196/annals.1346.047 1:CAS:528: DC%2BD28XntFentbc%3D 16831922 (Pubitemid 43824153)
53. H Hsu DL Lacey CR Dunstan I Solovyev A Colombero E Timms, et al. 1999 Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand Proc Natl Acad Sci USA 96 3540 5 10.1073/pnas.96.7.3540 1:CAS:528:DyaK1MXjslCitL8%3D 10097072 (Pubitemid 29168945)
54. MF Manolson H Yu W Chen Y Yao K Li RL Lees, et al. 2003 The a3 isoform of the 100-kDa V-ATPase subunit is highly but differentially expressed in large (>or=10 nuclei) and small (
55. R Iwasaki K Ninomiya K Miyamoto T Suzuki Y Sato H Kawana, et al. 2008 Cell fusion in osteoclasts plays a critical role in controlling bone mass and osteoblastic activity Biochem Biophys Res Commun 377 899 904 10.1016/j.bbrc.2008.10.076 1:CAS:528:DC%2BD1cXhsVais7rE 18952053
56. RL Lees VK Sabharwal JN Heersche 2001 Resorptive state and cell size influence intracellular pH regulation in rabbit osteoclasts cultured on collagen-hydroxyapatite films Bone 28 187 94 10.1016/S8756-3282(00)00433-6 1:CAS:528:DC%2BD3MXhtFehu7k%3D 11182377 (Pubitemid 32143685)
57. RL Lees JN Heersche 2000 Differences in regulation of pH(i) in large (≥10 nuclei) and small (≤5 nuclei) osteoclasts Am J Cell Physiol 279 C751 61 1:CAS:528:DC%2BD3cXmvVGrsr4%3D